The ICF syndrome, a DNA methyltransferase 3B deficiency and immunodeficiency disease.

[1]  A. Guala,et al.  Variability of clinical and immunological phenotype in immunodeficiency-centromeric instability-facial anomalies syndrome , 1995, European Journal of Pediatrics.

[2]  T. Meitinger,et al.  DNA, FISH and complementation studies in ICF syndrome: DNA hypomethylation of repetitive and single copy loci and evidence for a trans acting factor , 1995, Human Genetics.

[3]  A. T. Sumner,et al.  ICF syndrome (immunodeficiency, centromeric instability and facial anomalies): investigation of heterochromatin abnormalities and review of clinical outcome , 1995, Human Genetics.

[4]  D. Smeets,et al.  ICF syndrome: a new case and review of the literature , 1994, Human Genetics.

[5]  I. Tagarro,et al.  Chromosomal localization of human satellites 2 and 3 by a FISH method using oligonucleotides as probes , 1994, Human Genetics.

[6]  C. Romano,et al.  Multibranched chromosomes 1, 9, and 16 in a patient with combined IgA and IgE deficiency , 1979, Human Genetics.

[7]  J. Fryns,et al.  Centromeric instability of chromosomes 1, 9, and 16 associated with combined immunodeficiency , 2004, Human Genetics.

[8]  R. Jaenisch,et al.  Induction of Tumors in Mice by Genomic Hypomethylation , 2003, Science.

[9]  M. Lieber,et al.  The DNA methyltransferase-like protein DNMT3L stimulates de novo methylation by Dnmt3a , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[10]  T. Tada,et al.  Stage- and cell-specific expression of Dnmt3a and Dnmt3b during embryogenesis , 2002, Mechanisms of Development.

[11]  Y. Fukushima,et al.  Three novel DNMT3B mutations in Japanese patients with ICF syndrome. , 2002, American journal of medical genetics.

[12]  Q. Tao,et al.  Defective de novo methylation of viral and cellular DNA sequences in ICF syndrome cells. , 2002, Human molecular genetics.

[13]  P. Peterson,et al.  Imprinting regulator DNMT3L is a transcriptional repressor associated with histone deacetylase activity. , 2002, Nucleic acids research.

[14]  M. Ehrlich,et al.  DNA methylation in cancer: too much, but also too little , 2002, Oncogene.

[15]  R. Roberts,et al.  Co‐operation and communication between the human maintenance and de novo DNA (cytosine‐5) methyltransferases , 2002, The EMBO journal.

[16]  Albert Jeltsch,et al.  Molecular Enzymology of the Catalytic Domains of the Dnmt3a and Dnmt3b DNA Methyltransferases* 210 , 2002, The Journal of Biological Chemistry.

[17]  P. Laird,et al.  DNA Methyltransferase Deficiency Modifies Cancer Susceptibility in Mice Lacking DNA Mismatch Repair , 2002, Molecular and Cellular Biology.

[18]  J. P. Jackson,et al.  Control of CpNpG DNA methylation by the KRYPTONITE histone H3 methyltransferase , 2002, Nature.

[19]  Bert Vogelstein,et al.  DNMT1 and DNMT3b cooperate to silence genes in human cancer cells , 2002, Nature.

[20]  S. Henikoff,et al.  Genome-Wide Profiling of DNA Methylation Reveals Transposon Targets of CHROMOMETHYLASE3 , 2002, Current Biology.

[21]  G. Gimelli,et al.  A novel case of immunodeficiency, centromeric instability, and facial anomalies (the ICF syndrome): immunologic and cytogenetic studies. , 2002, Haematologica.

[22]  J. Chung,et al.  Dnmt3b, de novo DNA methyltransferase, interacts with SUMO-1 and Ubc9 through its N-terminal region and is subject to modification by SUMO-1. , 2001, Biochemical and biophysical research communications.

[23]  David E. Misek,et al.  DNA methyltransferase 3B mutations linked to the ICF syndrome cause dysregulation of lymphogenesis genes. , 2001, Human molecular genetics.

[24]  T. Bestor,et al.  Dnmt3L and the Establishment of Maternal Genomic Imprints , 2001, Science.

[25]  K. Muegge,et al.  Lsh, a member of the SNF2 family, is required for genome-wide methylation. , 2001, Genes & development.

[26]  S. Baylin,et al.  Dnmt3a and Dnmt3b Are Transcriptional Repressors That Exhibit Unique Localization Properties to Heterochromatin* , 2001, The Journal of Biological Chemistry.

[27]  J. Bender,et al.  Arabidopsis cmt3 chromomethylase mutations block non-CG methylation and silencing of an endogenous gene. , 2001, Genes & development.

[28]  K. Lam,et al.  B-Cell Maturation Protein, Which Binds the Tumor Necrosis Factor Family Members BAFF and APRIL, Is Dispensable for Humoral Immune Responses , 2001, Molecular and Cellular Biology.

[29]  N. Dillon,et al.  Binding of Ikaros to the λ5 promoter silences transcription through a mechanism that does not require heterochromatin formation , 2001, The EMBO journal.

[30]  K. Muegge,et al.  Lsh, a SNF2 family member, is required for normal murine development. , 2001, Biochimica et biophysica acta.

[31]  S. Gasser,et al.  Positions of Potential:Nuclear Organization and Gene Expression , 2001, Cell.

[32]  R. Martienssen,et al.  Robertson's Mutator transposons in A. thaliana are regulated by the chromatin-remodeling gene Decrease in DNA Methylation (DDM1). , 2001, Genes & development.

[33]  R. Frants,et al.  Active genes in junk DNA? Characterization of DUX genes embedded within 3.3 kb repeated elements. , 2001, Gene.

[34]  T. de Ravel,et al.  The ICF syndrome: new case and update. , 2001, Genetic counseling.

[35]  S. Gasser.  Positions of Potential , 2001 .

[36]  C. Wijmenga,et al.  Genetic variation in ICF syndrome: Evidence for genetic heterogeneity , 2000, Human mutation.

[37]  M. Ehrlich,et al.  Hypersensitivity to radiation-induced non-apoptotic and apoptotic death in cell lines from patients with the ICF chromosome instability syndrome. , 2000, Mutation research.

[38]  C. Wijmenga,et al.  Escape from gene silencing in ICF syndrome: evidence for advanced replication time as a major determinant. , 2000, Human molecular genetics.

[39]  J. Inoue,et al.  TNF Receptor Family Member BCMA (B Cell Maturation) Associates with TNF Receptor-Associated Factor (TRAF) 1, TRAF2, and TRAF3 and Activates NF-κB, Elk-1, c-Jun N-Terminal Kinase, and p38 Mitogen-Activated Protein Kinase1 , 2000, The Journal of Immunology.

[40]  M. Ehrlich,et al.  DNA hypomethylation and unusual chromosome instability in cell lines fromICF syndrome patients , 2000, Cytogenetic and Genome Research.

[41]  J. Cyster,et al.  RGS Molecule Expression in Murine B Lymphocytes and Ability to Down-Regulate Chemotaxis to Lymphoid Chemokines1 2 , 2000, The Journal of Immunology.

[42]  Don Foster,et al.  TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease , 2000, Nature.

[43]  D. Higgs,et al.  Mutations in ATRX, encoding a SWI/SNF-like protein, cause diverse changes in the pattern of DNA methylation , 2000, Nature Genetics.

[44]  R. Kuick,et al.  Whole-genome methylation scan in ICF syndrome: hypomethylation of non-satellite DNA repeats D4Z4 and NBL2. , 2000, Human molecular genetics.

[45]  N. Bérubé,et al.  Cell cycle-dependent phosphorylation of the ATRX protein correlates with changes in nuclear matrix and chromatin association. , 2000, Human molecular genetics.

[46]  C. Moratz,et al.  Regulator of G Protein Signaling 1 (RGS1) Markedly Impairs Giα Signaling Responses of B Lymphocytes , 2000, The Journal of Immunology.

[47]  C. Murre,et al.  Thymocyte selection is regulated by the helix-loop-helix inhibitor protein, Id3. , 2000, Immunity.

[48]  C. Wijmenga,et al.  The DNMT3B DNA methyltransferase gene is mutated in the ICF immunodeficiency syndrome. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[49]  N. Tommerup,et al.  Chromosome instability and immunodeficiency syndrome caused by mutations in a DNA methyltransferase gene , 1999, Nature.

[50]  C. Papadopoulos,et al.  Nanoelectronics: Growing Y-junction carbon nanotubes , 1999, Nature.

[51]  D. Haber,et al.  DNA Methyltransferases Dnmt3a and Dnmt3b Are Essential for De Novo Methylation and Mammalian Development , 1999, Cell.

[52]  J. Frederick,et al.  Impaired Immune Responses and B-Cell Proliferation in Mice Lacking the Id3 Gene , 1999, Molecular and Cellular Biology.

[53]  S. Pierce,et al.  MHC class II antigen processing in B cells: accelerated intracellular targeting of antigens. , 1999, Journal of immunology.

[54]  D. Bourc’his,et al.  Abnormal methylation does not prevent X inactivation in ICF patients , 1999, Cytogenetic and Genome Research.

[55]  P. Zwollo,et al.  B Cell-specific Activator Protein Prevents Two Activator Factors from Binding to the Immunoglobulin J Chain Promoter until the Antigen-driven Stages of B Cell Development* , 1999, The Journal of Biological Chemistry.

[56]  A. Fisher,et al.  Dynamic repositioning of genes in the nucleus of lymphocytes preparing for cell division. , 1999, Molecular cell.

[57]  M. Koshland,et al.  Myocyte Enhancer Factor-related B-MEF2 Is Developmentally Expressed in B Cells and Regulates the Immunoglobulin J Chain Promoter* , 1998, The Journal of Biological Chemistry.

[58]  R. Aebersold,et al.  RGSZ1, a G(z)-selective rgs protein in brain: Structure, membrane association, regulation by Gα(z) phosphorylation, and relationship to a G(z) gtpase-activating protein subfamily , 1998 .

[59]  A. T. Sumner,et al.  A FISH study of chromosome fusion in the ICF syndrome: involvement of paracentric heterochromatin but not of the centromeres themselves. , 1998, Journal of medical genetics.

[60]  S. Baylin,et al.  Hypomethylation of pericentromeric DNA in breast adenocarcinomas , 1998, International journal of cancer.

[61]  C. Wijmenga,et al.  Localization of the ICF syndrome to chromosome 20 by homozygosity mapping. , 1998, American journal of human genetics.

[62]  E. Leung,et al.  The β7 integrin gene (Itgb-7) promoter is responsive to TGF-β1: defining control regions , 1998, Immunogenetics.

[63]  G. Lyons,et al.  Characterization of myocyte enhancer factor 2 (MEF2) expression in B and T cells: MEF2C is a B cell-restricted transcription factor in lymphocytes. , 1998, Molecular immunology.

[64]  A. Gilman,et al.  Mammalian RGS Proteins: Barbarians at the Gate* , 1998, The Journal of Biological Chemistry.

[65]  M. Ehrlich,et al.  DNA demethylation and pericentromeric rearrangements of chromosome 1. , 1997, Mutation research.

[66]  D. Bourc’his,et al.  α-Satellite DNA methylation in normal individuals and in ICF patients: heterogeneous methylation of constitutive heterochromatin in adult and fetal tissues , 1997, Human Genetics.

[67]  M. Ehrlich,et al.  Preferential induction of chromosome 1 multibranched figures and whole-arm deletions in a human pro-B cell line treated with 5-azacytidine or 5-azadeoxycytidine. , 1997, Cytogenetics and cell genetics.

[68]  R. Kuick,et al.  Demethylation of repetitive DNA sequences in neuroblastoma , 1996, Genes, chromosomes & cancer.

[69]  T. Kakutani,et al.  Developmental abnormalities and epimutations associated with DNA hypomethylation mutations. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[70]  S. Dellaporta,et al.  Demethylation-Induced Developmental Pleiotropy in Arabidopsis , 1996, Science.

[71]  J. Rigaut,et al.  BCMAp: an integral membrane protein in the Golgi apparatus of human mature B lymphocytes. , 1995, International immunology.

[72]  J. Sawyer,et al.  Chromosome instability in ICF syndrome: formation of micronuclei from multibranched chromosomes 1 demonstrated by fluorescence in situ hybridization. , 1995, American journal of medical genetics.

[73]  A. Niveleau,et al.  Abnormal methylation pattern in constitutive and facultative (X inactive chromosome) heterochromatin of ICF patients. , 1994, Human molecular genetics.

[74]  J E Hewitt,et al.  Analysis of the tandem repeat locus D4Z4 associated with facioscapulohumeral muscular dystrophy. , 1994, Human molecular genetics.

[75]  R. Berger,et al.  The BCMA gene, preferentially expressed during B lymphoid maturation, is bidirectionally transcribed. , 1994, Nucleic acids research.

[76]  R. Martienssen,et al.  Arabidopsis thaliana DNA methylation mutants. , 1993, Science.

[77]  F. Ledeist,et al.  An embryonic-like methylation pattern of classical satellite DNA is observed in ICF syndrome. , 1993, Human molecular genetics.

[78]  G. Gimelli,et al.  ICF syndrome with variable expression in sibs. , 1993, Journal of medical genetics.

[79]  Rudolf Jaenisch,et al.  Targeted mutation of the DNA methyltransferase gene results in embryonic lethality , 1992, Cell.

[80]  P. Lorenz,et al.  [ICF syndrome. Immunodeficiency, chromosomal centromere instability, facial anomalies. Case report and literature review]. , 1992, Monatsschrift Kinderheilkunde : Organ der Deutschen Gesellschaft fur Kinderheilkunde.

[81]  P. Lorenz,et al.  ICF-Syndrom : Immunodefizienz, chromosomale Zentromerinstabilität, faziale Anomalien Fallvorstellung und Literaturübersicht , 1992 .

[82]  G. Holmgren,et al.  Fragility of the Centromeric Region of Chromosome 1 Associated with Combined Immunodeficiency in Siblings A Recessively Inherited Entity? , 1990, Acta paediatrica Scandinavica.

[83]  J. Kemp,et al.  Transferrin receptor synthesis is an early event in B cell activation. , 1989, Journal of immunology.

[84]  F. Ledeist,et al.  Multibranched chromosomes in the ICF syndrome: immunodeficiency, centromeric instability, and facial anomalies. , 1989, American journal of medical genetics.

[85]  R. Blaese,et al.  Variable immunodeficiency with abnormal condensation of the heterochromatin of chromosomes 1, 9, and 16. , 1988, The Journal of pediatrics.

[86]  O. Zuffardi,et al.  Immunodeficiency, centromeric heterochromatin instability of chromosomes 1, 9, and 16, and facial anomalies: the ICF syndrome. , 1988, Journal of medical genetics.

[87]  G. Vălkova,et al.  Centromeric instability of chromosomes 1, 9 and 16 with variable immune deficiency. Support of a new syndrome , 1987, Clinical genetics.

[88]  F. Harris,et al.  Centromeric instability of chromosomes 1 and 16 with variable immune deficiency: a new syndrome , 1985, Clinical genetics.

[89]  FOUL AABEL Østergaard.  A GIRL WITH RECURRENT INFECTIONS, LOW IgM AND AN ABNORMAL CHROMOSOME NUMBER 1 , 1973 .